aclacinomycin has been researched along with losartan potassium in 1 studies
| Studies (aclacinomycin) | Trials (aclacinomycin) | Recent Studies (post-2010) (aclacinomycin) | Studies (losartan potassium) | Trials (losartan potassium) | Recent Studies (post-2010) (losartan potassium) |
|---|---|---|---|---|---|
| 168 | 8 | 21 | 24,390 | 2,493 | 5,408 |
| Protein | Taxonomy | aclacinomycin (IC50) | losartan potassium (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 8.53 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0049 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
| 5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.0082 | |
| Type-1 angiotensin II receptor | Cavia porcellus (domestic guinea pig) | 0.018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacquot, R; Jardillier, JC; Jeannesson, P; Mayeux, P; Nyoung, MN; Trentesaux, C | 1 |
1 other study(ies) available for aclacinomycin and losartan potassium
| Article | Year |
|---|---|
Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells.
Topics: Aclarubicin; Adjuvants, Immunologic; Binding Sites; Cell Differentiation; Erythroid Precursor Cells; Erythropoietin; Hemoglobins; Humans; Leukemia, Erythroblastic, Acute; Receptors, Cell Surface; Receptors, Erythropoietin | 1991 |